Commentary: Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis

by Thomas J Wilkinson
Published 2015-12-01

Determinants of patient activation and its association with cardiovascular disease risk in chronic kidney disease: A cross‐sectional study

by Thomas J. Wilkinson, Katherine Memory, Courtney J. Lightfoot, Jared Palmer, Alice C. Smith
Published 2021-06-01

Commentary: Renal Function Estimation and Cockcroft–Gault Formulas for Predicting Cardiovascular Mortality in Population-Based, Cardiovascular Risk, Heart Failure and Post-Myocardi...

by Thomas J. Wilkinson, Douglas W. Gould, Emma L. Watson, Alice C. Smith, Alice C. Smith
Published 2017-06-01

Differences in physical symptoms between those with and without kidney disease: a comparative study across disease stages in a UK population

by Thomas J. Wilkinson, Daniel G. D. Nixon, Jared Palmer, Courtney J. Lightfoot, Alice C. Smith
Published 2021-04-01

Response of the oxygen uptake efficiency slope to exercise training in patients with chronic kidney disease

by Thomas J. Wilkinson, Emma L. Watson, Noemi Vadaszy, Luke A. Baker, João L. Viana, Alice C. Smith
Published 2020-09-01

Ultrasound assessment of muscle mass in response to exercise training in chronic kidney disease: a comparison with MRI

by Douglas W. Gould, Emma L. Watson, Thomas J. Wilkinson, Joanne Wormleighton, Soteris Xenophontos, Joao L. Viana, Alice C. Smith
Published 2019-08-01

Association of sarcopenia with mortality and end‐stage renal disease in those with chronic kidney disease: a UK Biobank study

by Thomas J. Wilkinson, Joanne Miksza, Thomas Yates, Courtney J. Lightfoot, Luke A. Baker, Emma L. Watson, Francesco Zaccardi, Alice C. Smith
Published 2021-06-01